1 |
Was the rationale of the research described? |
|
|
|
2 |
Were the objectives of the research clearly stated? |
|
|
|
3 |
Was the study a prospective cohort study? |
|
|
|
4 |
Was the follow-up of the cohort study 5 years or longer? |
|
|
|
5 |
Were the key-elements of the study design described? |
|
|
|
6 |
Were the setting, relevant dates and timeframe of the research described? |
|
|
|
7 |
Were the eligibility criteria for participants described? |
|
|
|
8 |
Were the participants free of disability at baseline? |
|
|
|
9 |
Were the predictors and dependent variables described? |
|
|
|
10 |
Were the measurement methods for the predictors and dependent variables described? |
|
|
|
11 |
Were standardized or valid measurements used for the predictors? |
|
|
|
12 |
Were standardized or valid measurements used for the outcome? |
|
|
|
13 |
Were potential types of bias addressed? |
|
|
|
14 |
Was it clear how the quantitative data were handled in the analyses? |
|
|
|
15 |
Were appropriate multivariate analysis techniques used? |
|
|
|
16 |
Did the statistical methods control for confounding and examine subgroups or interactions? |
|
|
|
17 |
Was there a description on how the final number of participants was established? |
|
|
|
18 |
Was the (loss to) follow-up of the participants described? |
|
|
|
19 |
Was the attrition less than 20%? |
|
|
|
20 |
Was information provided regarding the baseline characteristics of participants? |
|
|
|
21 |
Was the number of outcome events or summary measures over time reported? |
|
|
|
22 |
Were the results expressed in an Odds Ratio (OR), Risk Ratio (RR) or Hazard Ratio (HR) with the corresponding 95% confidence interval? |
|
|
|
23 |
If sub-group analyses were performed, were these clearly described? |
|
|
|
24 |
Were the key-results described in the discussion? |
|
|
|
25 |
Were the limitations of the study reported? |
|
|
|
26 |
Were previous research and the limitations of the study taken into account when an overall interpretation of the study results was provided? |
|
|
|
27 |
Was the generalisability of the study results described? |
|
|